Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 2 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

0
Player Avatar jeffreykoo (< 20) Submitted: 5/4/2007 11:41:19 AM : Outperform Start Price: $16.98 ENZ Score: -80.93

stock price moved upwards in spite of negative consensus. In stock market peple who vote with their money (buying power)ften overweight people vote with their heart. A company no one loves usually does better in the long run.

Featured Broker Partners


Advertisement